Apogee Therapeutics
Apogee Therapeutics, a Nasdaq-listed biotechnology company founded in 2022, is hiring an Associate Director to join its QC Analytical Sciences team within Analytical Development & Quality Control. The role supports analytical testing oversight across the company’s biologics development pipeline, working with cross-functional internal teams and external partners to advance product development and quality activities.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2022
Apogee Therapeutics is a clinical-stage biotechnology company developing differentiated biologics for immunological and inflammatory diseases. The company focuses on high-unmet-need conditions including atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other I&I disorders. Apogee advances therapeutic candidates through clinical development with the goal of delivering best‑in‑class treatments for patients with inflammatory and immune-mediated diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Apogee Therapeutics.
A Look At Apogee Therapeutics (APGE) Valuation After Wider Losses And A New Shelf Registration
2 days ago
Senior Scientist I, Biologics Analytical R&D, Analytical Development-Early Stage
AbbVie
Senior Scientist I
AbbVie
Senior Manager, Analytical Development
CG Oncology
Associate Director, Analytical Development
Cogent Biosciences
Principal Research Scientist II - Analytical Development
AbbVie
Scientist II, Analytical Development
Vaxcyte